Related content

An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples

By Di Lorenzo Giuseppe   Casciano Roman   Malangone Elisabetta   Buonerba Carlo   Sherman Steven   Willet Jacob   Wang Xufang   Liu Zhimei   De Placido Sabino  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1491-1497

Informa Healthcare

Access to resources Recommend Favorite

Authors reply: an adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples

By Di Lorenzo Giuseppe   Casciano Roman   Malangone Elisabetta   Buonerba Carlo   Sherman Steven   Willet Jacob   Wang Xufang   Liu Zhimei   De Placido Sabino  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1079-1080

Informa Healthcare

Access to resources Recommend Favorite

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

By  

Current Cancer Drug Targets, Vol. 11, Iss. 8, 2011-10 ,pp. : 944-953

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene   Keating Gillian M.  

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Sorafenib/sunitinib: First report of atrial fibrillation and myocardial ischaemia following sequential therapy: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1188, 2008-01 ,pp. : 20-21

Adis International

Access to resources Recommend Favorite